Bowen's disease (squamous cell carcinoma in situ)

What changed: Bowen's disease (squamous cell carcinoma in situ)

Every dated change on the records linked to Bowen's disease (squamous cell carcinoma in situ), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Guideline1This record1On Edge

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-25This recordBowen's disease (squamous cell carcinoma in situ)
Facts on this page last checked
When this page itself was last checked or edited.

2022 · 1

2022GuidelineBowen's disease (squamous cell carcinoma in situ)
Guideline British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma in situ (Bowen disease) 2022: Typical lesion
Topical fluorouracil or imiquimod, cryotherapy, curettage and cautery, photodynamic therapy, surgical excision, Mohs surgery, radiotherapy or laser; Cancer Research UK states that all of these can work well and that cure rates are high. The choice is driven by the site, the size, how well the skin there heals and what the person can manage at home. The treatment layer of this family carries the detail.